| __timestamp | BioCryst Pharmaceuticals, Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13608000 | 751040000 |
| Thursday, January 1, 2015 | 48257000 | 889895000 |
| Friday, January 1, 2016 | 26353000 | 1116854000 |
| Sunday, January 1, 2017 | 25186000 | 1313646000 |
| Monday, January 1, 2018 | 20653000 | 1491212000 |
| Tuesday, January 1, 2019 | 48835000 | 1704048000 |
| Wednesday, January 1, 2020 | 17812000 | 1860455000 |
| Friday, January 1, 2021 | 157170000 | 1846275000 |
| Saturday, January 1, 2022 | 270827000 | 2096039000 |
| Sunday, January 1, 2023 | 331412000 | 2419226000 |
In pursuit of knowledge
In the competitive world of biotechnology, revenue growth is a key indicator of success. Over the past decade, BioMarin Pharmaceutical Inc. and BioCryst Pharmaceuticals, Inc. have shown contrasting trajectories. BioMarin, with its robust pipeline, has seen its revenue soar by over 220% from 2014 to 2023, reaching a peak of approximately $2.42 billion in 2023. This growth underscores BioMarin's strategic focus on rare genetic diseases, which has paid off handsomely.
Conversely, BioCryst has experienced a more modest revenue increase, growing by nearly 2,300% over the same period, albeit from a much smaller base. By 2023, BioCryst's revenue reached around $331 million, reflecting its efforts to expand its portfolio in the antiviral and rare disease markets. This comparison highlights the diverse strategies and market positions of these two biotech firms, offering valuable insights into their future potential.
AstraZeneca PLC or BioMarin Pharmaceutical Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Gilead Sciences, Inc. or BioCryst Pharmaceuticals, Inc.?
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or BioMarin Pharmaceutical Inc.
Breaking Down Revenue Trends: Zoetis Inc. vs BioCryst Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.: A Comprehensive Revenue Analysis
Alnylam Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Incyte Corporation and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
BioMarin Pharmaceutical Inc. and Ascendis Pharma A/S: A Comprehensive Revenue Analysis
BioMarin Pharmaceutical Inc. or Geron Corporation: Who Leads in Yearly Revenue?
Revenue Showdown: BioMarin Pharmaceutical Inc. vs Evotec SE
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.
Merus N.V. vs BioCryst Pharmaceuticals, Inc.: Annual Revenue Growth Compared